1.93% -0.0143

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above 200 Day Moving Average of $0.00 - Defense World

Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving Average of $0.00 - MarketBeat

Xtant Medical (NYSEAMERICAN:XTNT) Stock Passes Above 200-Day Moving Average of $0.00 - Defense World

Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving Average of $0.00 - MarketBeat

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Large Decline in Short Interest - MarketBeat

Market Highlights: Xtant Medical Holdings Inc (XTNT) Ends on a Low Note at 0.72 – DWinneX - The Dwinnex

Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200 Day Moving Average of $0.00 - MarketBeat

Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200-Day Moving Average of $0.00 - Defense World

Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200 Day Moving Average of $0.00 - MarketBeat

Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29 - Yahoo Finance

Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29 - Yahoo Finance

Xtant Medical Enters Wound Care Market With Two Products - https://ryortho.com/

Xtant Medical Enters Wound Care Market With Two Products - https://ryortho.com/

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Raised to $3.00 - Defense World

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Raised to $3.00 - Defense World

Xtant Medical shares target raised by BTIG on strong Q1 results - Investing.com

Xtant Medical shares target raised by BTIG on strong Q1 results By Investing.com - Investing.com

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Raised to $3.00 - MarketBeat

Earnings call: Xtant Medical projects strong growth and increased revenue in 2024 - Investing.com Australia

Earnings call: Xtant Medical projects strong growth and increased revenue in 2024 By Investing.com - Investing.com UK

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2024 Earnings Call Transcript - Insider Monkey

Xtant Medical shares target raised by BTIG on strong Q1 results By Investing.com - Investing.com

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Passes Above 200 Day Moving Average of $0.00 - Defense World

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance - Yahoo Finance

Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00 - MarketBeat

Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance - Yahoo Finance

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 - Yahoo Finance

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 - Yahoo Finance

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds

Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds - OrthoSpineNews

Xtant Medical Holdings Inc Stock Quote | Stock Price for XTNT | FinancialContent Business Page - Financial Content

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript - Yahoo Finance

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million - OrthoSpineNews

Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024

Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

13 High Growth Penny Stocks That Are Profitable - Insider Monkey

Xtant Acquires NanOss Production Operations From RTI Surgical - Contract Pharma

Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical - OrthoSpineNews

Xtant Medical Highlights Growing Product Portfolio at NASS 2023 - OrthoSpineNews

Xtant Buys Surgalign’s Spine and Biologics Business for $5M - https://ryortho.com/

Xtant Medical completes $15m private placement - Medical Device Network

Xtant Medical closes $15M private placement - Mass Device

Surgalign Declares Bankruptcy - https://ryortho.com/

Surgalign (SRGA) Stock Rallied 96.2% Despite the Delisting Notice - AskTraders

Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale ... - GlobeNewswire

Xtant Medical completes acquisition of Surgalign product lines - Medical Device Network

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million - GlobeNewswire

Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment - OrthoSpineNews

XTNT: Does Xtant Medical Holdings Deserve a Spot in Your Portfolio? - StockNews.com

Simile a XTNT